Mind Medicine (MNMD) Tops Q2 EPS by 7c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit
• TJX stock drops as profit outlook falls short of analyst estimates